Cholamandalam Investment Allots ₹1,001 Cr Securities

2 min read     Updated on 24 Dec 2025, 09:29 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Cholamandalam Investment and Finance Company Limited has completed the allotment of secured non-convertible securities worth ₹1,001 crores through private placement. The securities offer an 8.20% coupon rate with a 2.15-year maturity period. The issue, part of a ₹1,500 crore total size including a ₹500 crore greenshoe option, comprises 100,100 securities to be listed on the WDM segment of NSE. The securities have annual coupon payments and are secured at 1x coverage.

28137536

*this image is generated using AI for illustrative purposes only.

Cholamandalam Investment and Finance Company Limited has completed the allotment of secured non-convertible securities worth ₹1,001 crores through private placement. The securities come with an 8.20% coupon rate and a maturity period of 2.15 years.

Securities Allotment Details

The company has provided comprehensive details regarding the securities allotment under Regulation 30 and 30(A) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The following table summarizes the key parameters of the allotted securities:

Parameter Details
Type of Security Secured Non-Convertible Securities
Issuance Type Private Placement NSE EBP
Number of Securities 100,100
Amount Allotted ₹1,001 crores
Total Issue Size ₹1,500 crores (including ₹500 crores greenshoe)
Listing Venue WDM Segment of NSE

Interest Rate and Maturity Structure

The securities offer attractive returns with a structured payment schedule designed for institutional investors. The interest rate framework and maturity details are outlined below:

Specification Terms
Maturity Period 2.15 years (785 days)
Coupon Rate 8.20%
Reissue Yield 7.54%
Coupon Frequency Annual (February 17) and on Maturity
Payment Dates February 17 every year and February 17, 2028
Security Coverage Secured at 1x

Regulatory Compliance and Risk Factors

The company has confirmed full compliance with listing regulations and provided necessary disclosures regarding the securities. Key regulatory aspects include:

  • No delays in payment of interest or principal amount for more than three months from due dates
  • No defaults in payment of interest or principal amounts reported
  • No adverse letters or comments regarding payment obligations
  • Securities do not involve preference share redemption or debenture-related complications

Issue Structure and Market Positioning

The allotment of ₹1,001 crores represents a substantial portion of the total issue size of ₹1,500 crores, which includes a greenshoe option of ₹500 crores. The securities are structured as secured instruments, providing additional safety to investors through asset backing. The listing in the WDM (Wholesale Debt Market) segment of NSE ensures appropriate market access for institutional participants.

The successful completion of this securities allotment demonstrates Cholamandalam Investment's continued access to capital markets and its ability to raise funds through debt instruments at competitive rates in the current market environment.

Historical Stock Returns for Cholamandalam Investment

1 Day5 Days1 Month6 Months1 Year5 Years
+1.15%+1.45%+2.79%+6.21%+43.22%+351.12%
Cholamandalam Investment
View in Depthredirect
like19
dislike

Cholamandalam Investment Management Defends Against Governance Allegations

3 min read     Updated on 24 Dec 2025, 08:01 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Cholamandalam Investment management has provided comprehensive clarifications against recent governance allegations, with Arul Selvan D stating the claims lack consistency and ignore regulatory evolution. The company explained insurance transaction rationales, executive compensation practices, and group service arrangements while maintaining strong financial metrics and positive brokerage ratings.

28132263

*this image is generated using AI for illustrative purposes only.

Cholamandalam Investment and Finance Company has mounted a comprehensive defense against recent governance allegations, with management providing detailed clarifications on various concerns raised. The company's proactive response helped calm market nerves, with shares gaining 6.4% to close at ₹1,680.60 on the BSE.

Management Calls Allegations Inconsistent and Context-Free

Speaking during an analyst call, Arul Selvan D from Cholamandalam Investment strongly pushed back against the allegations, stating they lack consistency and ignore the regulatory framework that existed at the time. "There is no consistency in the way these allegations have been approached. Different years have been selectively used to inflate numbers and portray a larger issue, without recognising that laws on related-party disclosures have evolved over time," he explained.

The management emphasized that all disclosures and transactions were carried out strictly in line with the laws prevailing then, and that judging past actions using today's norms creates a misleading impression. "At every point, the company ensured compliance with the law prevailing then. Applying current disclosure norms retrospectively and saying things were not disclosed earlier is completely incorrect," Arul Selvan D added.

Insurance Transaction Clarifications

Addressing allegations of fund diversion through insurance transactions, including the ₹3,040.00 crore transfer from Cholamandalam MS General Insurance to other Murugappa Group entities, management explained the business rationale behind these arrangements:

Transaction Details Explanation
Insurance Business Model Group policy offering insurance at lower costs to borrowers
Customer Base Largely 'earn-and-pay' customers requiring protection
Coverage Types Motor, health and life insurance for emergencies
Commission Structure Normal business practice with commissions paid back to Chola
Current Structure Chola now direct insurance agent due to IRDAI regulations

"Insurance ensures that the borrower's family is not burdened with loan repayments during emergencies. Even a one-month disruption in income can make it difficult for customers to pay EMIs, and medical insurance helps them manage such situations," Arul Selvan D explained.

Executive Compensation and Family Member Payments

Responding to allegations of excessive payments to family members and key managerial personnel, management clarified that promoter family members hold active executive positions. "Most family members hold executive positions and are deeply involved in day-to-day business operations. They are not non-executive promoters. Their contribution is visible, and compensation is aligned with industry standards," he stated.

The company emphasized that all remuneration follows due process, with salaries and commissions approved by the board and shareholders and benchmarked to industry practices.

Murugappa Management Services Payments Explained

Regarding concerns around payments made to Murugappa Management Services, management explained these related to an earlier group-level governance structure. "At the group level, we earlier had a corporate board with internal and external experts overseeing finance, HR and IT to ensure common practices across companies," Arul Selvan D clarified.

He added that from FY22, the group was reorganised into three verticals due to the scale of operations, and as each vertical built its own management framework, costs paid to Murugappa Management Services reduced significantly.

Strong Financial Position Reaffirmed

The company continues to emphasize its robust financial metrics and operational performance:

Financial Metric Value Details
Cash and Bank Balances ₹14,900.00 crore As of November 30
Capital Adequacy Ratio 19.79% Well above 15% statutory requirement
Tier I Capital 14.53% Above 10% statutory requirement
Net Worth ₹26,783.00 crore Increase of over ₹3,000.00 crore

In a comprehensive regulatory filing, the company categorically stated there has been no revision to its earlier guidance and that it will continue to deliver as per its board-approved business plan. All payments to board members and senior management have been made in compliance with applicable law and fully disclosed to shareholders.

Brokerage Firms Maintain Positive Outlook

Despite the allegations, major brokerages continue to maintain positive ratings on the stock. Motilal Oswal reiterated its 'Buy' rating with a target price of ₹2,000.00, while Morgan Stanley maintained an 'Equal-weight' rating with a target price of ₹1,540.00. Jefferies sustained its 'Buy' rating with a target price of ₹1,980.00, stating that governance-related allegations appear misplaced.

Concluding his response, Arul Selvan D expressed disappointment that the allegations were raised without engagement. "These issues could have been clarified through discussion. Instead, conclusions were drawn without understanding the full context, creating an unnecessary controversy."

Historical Stock Returns for Cholamandalam Investment

1 Day5 Days1 Month6 Months1 Year5 Years
+1.15%+1.45%+2.79%+6.21%+43.22%+351.12%
Cholamandalam Investment
View in Depthredirect
like15
dislike
More News on Cholamandalam Investment
Explore Other Articles
1,697.80
+19.30
(+1.15%)